期刊文献+

胆道闭锁异常肝组织蛋白筛查及预后相关性研究 被引量:2

Abnormal expression of hepatic protein and its relationship to prognosis in children with biliary atresia
原文传递
导出
摘要 目的 初步鉴定胆道闭锁肝组织异常蛋白表达情况,寻找与胆道闭锁发病和预后有关的差异表达蛋白。方法 用固相pH梯度双向凝胶电泳分离胆道闭锁和正常肝脏组织总蛋白,银染显色,Melanie3.02 2D图像分析软件分析,对部分蛋白质点用基质辅助激光解析电离飞行时间质谱(MALDI-TOF-MS)进行鉴定,查询数据库鉴定差异蛋白质。结果获得了背景清晰、分辨率和重复性较好的双向凝胶电泳图谱,蛋白质匹配率达80%以上。胆道闭锁和正常组比较发现表达量变化达2倍以上的蛋白点有33个,表达量变化达4倍以上者有8个。胆道闭锁预后较好者和预后不好者比较发现表达量变化达4倍以上的蛋白点有22个,表达量变化达5倍以上者有18个。质谱鉴定其中15个点,其中7个点鉴定成功,分别是Viperin、SARMl、GPC3、APC、THUM2、MIA3和KIAA0649。结论 本研究成功鉴定出部分与胆道闭锁发病和预后有关的蛋白质,为进一步研究胆道闭锁致病机制和提高手术预后提供了新的研究方向,有进一步研究的价值。 Objective To investigate the expression of hepatic protein in patients with biliary atresia(BA), and find the relationship between the significant protein and prognosis of biliary atresia. Methods Immobile pH gradients isoelectric focusing was used as 1D, and vertical SDS-PAGE as 2D. Sliver staining, Melanie3. 02 2D analysis software, matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) and NCBInr database searching were used to separate and identify the proteome from liver in patients with biliary atresia. Results Satisfactory 2DE patterns were obtained. Thirty-three protein spots were remarkably changed in patients with biliary atresia compared with the control group. Twenty-two protein spots were significantly difference between BA patients with good prognosis and BA patients with poor prognosis. Fifteen protein spots were referred to mass spectrometry, and 7 protein spots were identified, including Viperin, SARM1, GPC3, APC, THUM2, MIA3 and KIAA0649. Conclusions In this study, proteins related to the prognosis and pathogenesis of biliary atresia were identified, which may contribute to prognosis and pathogenesis of biliary atresia.
出处 《中华小儿外科杂志》 CSCD 北大核心 2011年第3期169-173,共5页 Chinese Journal of Pediatric Surgery
基金 国家十一五课题(2006BAI05A00) 北京市科技计划课题(首都临床特色应用研究)
关键词 胆道闭锁 光谱分析 质谱 预后 Biliary atresia Spectrum analysis, mass Prognosis
  • 相关文献

参考文献18

  • 1Balistreri WF, Grand R, Hoofnagle JH, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology, 1996,23(6) : 1682-1692.
  • 2Leonhardt J, Kuebler JF, Turowski C, et al. Predictive parameters in children with biliary atresia. Chirurg, 2009, 80 (7) : 628633.
  • 3Chin KC,Cresswell P. Viperin(cig 5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. PNAS,2001,98(26) : 15125-15130.
  • 4Hinson ER. Biochemical and functional characterization of the interferon-induced antiviral protein viperin. J Interferon Cytokine Res,2009, 29(12) : 826.
  • 5Shen C, Zheng S,Wang W, et al. Relationship between prognosis of biliary atresia and infection of cytomegalovirus. World J Pediatr,2008,4(2) :123-126.
  • 6Urushihara N, Iwaqaki H, Yaqi T, et al. Elevation of serum interleukin-18 levels and activation of kupffer cells in biliary atresia. J Pediatr Surg,2000, 35(3) : 446-449.
  • 7Carty M,Goodbody R, Schr0der M,et al. The human adaptor SARM negatively regulates adaptor protein TRIFdependent Toll-like receptor signaling. Nat Immunol, 2006, 7(10):10741081.
  • 8Sheedy FJ, O'Neill LA. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J Leukoc Biol, 2007, 82(2) : 196-203.
  • 9Ahmed AF, Nio M, Ohtani H, et al. In situ CD14 expression in biliary atresia: comparison between early and late stages. J Pediatr Surg, 2001, 36(1) :240-243.
  • 10Danielle F, Cano G, Howard HS, et al. Glypican-3 deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-GolabiBehmel Syndrome. J Cell Biol, 1999,146 ( 1 ) : 255-264.

同被引文献19

  • 1Hartley JL, Davenport M, Kelly DA. Biliary atresia [J]. Lancet, 2009,374 (9702) : 1704-1713.
  • 2Wang L,Dai Y, Qi S, et al. Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics [J ]. Rheumatol Int, 2012,32 (3) .. 585-93.
  • 3Rehman I, Evans CA, Glen A. et al. iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer[J]. PLoS One, 2012,7 (2) : e30885.
  • 4Hou Q, Tan HT, Lira KH, et al. Identification and functional validation of caldesmon as a potential gastric cancer metastasis- associated protein[J]. JProteome Res, 2013,12 ( 2 ) : 980-990.
  • 5Petersen C,Davenport M. Aetiology of biliary atresia: what is actually known? [J]. Orphanet J Rare Dis,2013,8(1) : 128.
  • 6Wildhaber BE. Biliary atresia:50 years after the first kasai[J]. ISRN Surg,2012,2012:132089.
  • 7Kobayashi H, Purl P, OBriain DS, et al. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis[J]. J Pediatr Surg, 1997,32 (4) : 590-593.
  • 8Mack CL, Anderson KM, Aubrey MT, et al. Lack of HLA predominance and HLA shared epitopes in biliary atresia[J]. Springerplus, 2013,2 ( 1 ) : 42.
  • 9Yuasa T,Tsuji H,Kimura S, et al. Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation [J]. Hum Immunol,2005 ,66(3) :295-300.
  • 10Feng J,Li M, Gu W, et al. The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia., an immunohistochemistry and immune electron microscopy study I-J. J Pediatr Surg,2004,39(ll) :1658-1662.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部